Menu

• Ask a Health Expert about CYTOGENETIC ANALYSIS ABNORMAL
• Post Your Side Effect related to CYTOGENETIC ANALYSIS ABNORMAL
• CYTOGENETIC ANALYSIS ABNORMAL and FDA Warnings
• CYTOGENETIC ANALYSIS ABNORMAL in Patients Wiki
• Report CYTOGENETIC ANALYSIS ABNORMAL in Drug Side Effect Survey

CYTOGENETIC ANALYSIS ABNORMAL side effect

What is CYTOGENETIC ANALYSIS ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Keppra Side Effects Report #5587643-7
Health Professional from UNITED STATES reported KEPPRA problem on Dec 31, 2007. Female patient, weighting 11.46 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: cytogenetic analysis abnormal, . KEPPRA dosage: 2000 MG/D TRP. During the same period patient was treated with PRENATAL VITAMINS, FOLIC ACID, VALTREX. Patient recovered.

Imatinib Side Effects Report #5762308-7
IMATINIB MESYLATE problem was reported by a Health Professional from HUNGARY on May 27, 2008. Male patient was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: cytogenetic analysis abnormal, . IMATINIB MESYLATE dosage: unknown. Patient recovered.

Imatinib Side Effects Report #5762310-5
Health Professional from HUNGARY reported IMATINIB MESYLATE problem on May 27, 2008. Female patient was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: cytogenetic analysis abnormal, . IMATINIB MESYLATE dosage: unknown. Patient recovered.

Vincristine Side Effects Report #5712880-8
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 30 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic analysis abnormal, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.


Imatinib Side Effects Report #5669602-9
Health Professional from TURKEY reported IMATINIB problem on Mar 07, 2008. Male patient, 17 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: asthenia, chloroma, cytogenetic analysis abnormal, fatigue, haemoglobin decreased, hepatosplenomegaly, malignant neoplasm progression, mass, oedema, . IMATINIB dosage: 400 MG/D. Patient died.